• Hill-Rom
  • LikoGuard
  • Stamp
  • The Vest
  • Progressive Mobility Program

News and Events

Hill-Rom Declares Fourth Quarter 2015 Dividend

CHICAGO, July 22, 2015 - Hill-Rom Holdings, Inc., (NYSE: HRC) announced today that its Board of Directors declared a fiscal year 2015 fourth quarter dividend of $0.16 per share.  This quarterly dividend represents a 5 percent increase over the amount paid a year ago.  The dividend is payable on September 30, 2015 to shareholders of record as of the close of business on September 16, 2015. 

Hill-Rom Holdings, Inc. Hosts Fiscal 2015 Third Quarter Earnings Conference Call and Webcast

CHICAGO, Ill., July 13, 2015 -- Hill-Rom Holdings, Inc., (NYSE:HRC) will hold its fiscal 2015 third quarter earnings conference call and webcast from 8:00 a.m. – 9:00 a.m. ET on the morning of Friday, August 7, 2015.  

Advanced Monitoring System Dramatically Improves Hand Washing by Health Care Workers

Hill-Rom Hand Hygiene Compliance Solution Significantly Increases Caregiver Compliance

CHICAGO, Ill., June 26, 2015 – New data from Hill-Rom (NYSE: HRC) shows its hand-hygiene compliance system dramatically increases hand washing among hospital staff using the system.  Analysis of more than 20 million instances of hand washing shows institutions using Hill-Rom’s Hand Hygiene Compliance Solution have achieved an average 226% improvement in compliance, with some institutions showing compliance by caregivers nearly tripled.  

Hill-Rom To Acquire Welch Allyn Creating Global Leader in Patient Care Solutions

CHICAGO and SKANEATELES FALLS, N.Y., June 17, 2015 - Two of the world's leading healthcare technology companies are joining forces to make possible the development of leading-edge solutions that will advance patient care around the world. Hill-Rom Holdings, Inc. (NYSE: HRC) ("Hill-Rom") and privately-held Welch Allyn, Inc. ("Welch Allyn") today announced that the Board of Directors of both companies have unanimously approved a definitive agreement under which Hill-Rom will acquire Welch Allyn for approximately $2.05 billion in cash and stock. The two companies have nearly two centuries of medical device innovation between them and will combine their unique strengths to develop new technologies that enhance outcomes for patients and their caregivers.